[Immunotherapy in HIV infection].
Solignac
Marie
M
D016915:AIDS Vaccines; D000998:Antiviral Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D016896:Treatment Outcome
D016915:AIDS Vaccines; D000998:Antiviral Agents; D007155:Immunologic Factors; D016898:Interferon-alpha; D007376:Interleukin-2